The Latest Biology News And Medical NewsBiology News 2Health News 2Biology News 3Health News 3
HOME >> MEDICINE >> NEWS
Clinical trial data for Perforomist Inhalation Solution to be presented at ATS on May 20, 2007

Napa, CA (May 16, 2007) Dey, L.P. announced that two clinical data presentations will be given at the International Conference of the American Thoracic Society (ATS) on Sunday, May 20, at the Moscone Center in San Francisco. The presentations will detail Phase III clinical data demonstrating the safety and efficacy of Perforomist (formoterol fumarate) Inhalation Solution, approved on May 11 by the FDA for long-term, twice-daily maintenance treatment of bronchoconstriction for emphysema and chronic bronchitis, also known as Chronic Obstructive Pulmonary Disease (COPD).

For those attending ATS, the two presentations are available as follows:

  • "Nebulized Formoterol is an Effective Bronchodilator and Improves the Quality of Life for COPD Patients," Poster Board #A10, Publ. pg. A128.

  • "Safety Profile of Formoterol Fumarate Delivered by Nebulization to COPD Patients," Poster Board #A11, Publ. pg. A128

Poster Viewing: 10:45 AM - 12:15 PM
Room: Area A (Hall D, Lower Level), Moscone Center
Session Info: Thematic Poster Session, [A47] COPD Treatment I: Bronchodilators, Inhaled Corticosteroids and PDE4 Inhibitors.

Please note that the principal investigators will be available to discuss the research results.


'"/>

Contact: Harriet Ullman
harriet.ullman@fkhealth.com
617-761-6776
Feinstein Kean Healthcare
16-May-2007


Page: 1

Related medicine news :

1. Clinical data suggest potential versatility of ALIMTA-based regimens in lung cancer
2. Susan G. Komen for the Cure and American Society of Clinical Oncology partner in national initiative
3. Clinical review -- A psychological approach to the management of irritable bowel syndrome
4. NHLBI Asthma Clinical Research Networks and ALA ACRC Network to present at ATS 2007
5. Clinical trial data for Perforomist Inhalation Solution presented at International ATS Conference
6. Clinical guidelines for blood conservation during cardiac procedures developed
7. Clinical trial coordinators need more financial conflict-of-interest training
8. Clinical studies evaluate potential treatments for mouth ulcers
9. NIH names Clinical Trial Units for the Microbicide Trials Network
10. Clinical Trials Units selected for newly restructured HIV/AIDS research networks
11. Study in recent issue of Clinical Pediatrics helps pediatricians to understand discipline practices

Post Your Comments:
(Date:11/23/2009)...approval process in United States, researcher says... Problems with the popular arthritis drug Vioxx, i...nd death, were known for years before the drug,s v... report says. , Contrary to claims by the manu...were evident in 2000, a year after the drug was pu...
(Date:11/23/2009)...ewswire/--Hazelden,theinternationallyrenownednonpr...ershipteamforitsnewrecoverycenterinNaples,Florida....nlateMarch2010,andwillinitiallyprovideaddictiontre...yandoutpatientservices. ,, MichaelDemask,Ph.D.,...Naples,withBrendaIliff,M.A.,L.A.D.C.,asclinicaldir...
(Date:11/23/2009)...nce"reform"isamoraloutrage ,, WASHINGTON,Nov....movedforwardtobeginthedebateontheirhealthcare"refo...onggrassrootssenioradvocacygroup,iscallingonallofA...sivecutstoMedicare.RetireSafePresidentThairPhillip...taxes,abortion,andimmigration,whilethesimple,uncom...
(Date:11/23/2009)... ,, WHAT: ,, TheBerylInstitute, theresear...,sleadinghealthcareexclusivecallcenter,issponsorin...rygenerationwithapositivecustomerserviceexperience...ebinarwillsupplementHowe,sJune2009whitepaper,"Cust...usseshowconsumerswillultimatelytransformhealthcare...
(Date:11/23/2009)...ire/--CortivaInstituteTucsonwillhostanIntroduction...ttheschool,s6390EastBroadwayBlvd.location,whichwil...ticebasicmassagestrokes. ,, "Massagetherapyisag...alongwithit,"saidJoannMcMaster,presidentofCortivaI...bor,s2009-2010OccupationalOutlookHandbookstatestha...
Breaking Medicine News(10 mins):Health News: Vioxx Problems Known Years Before Recall 2Health News: Vioxx Problems Known Years Before Recall 3Health News: Vioxx Problems Known Years Before Recall 4Health News:Hazelden Names Leadership Team for New Recovery Center in Naples, Florida 2Health News:RetireSafe Calls on Seniors to Grab their Bullhorns to Save Medicare from Rationed Care 2Health News:Tips to Improve Healthcare Customer Service Across All Generations 2Health News:Cortiva Institute To Host Workshop, Hands-On Opportunity for Prospective Students 2
(Date:11/23/2009)...CryoLife,Inc. (NYSE: CRY ),animplantablebiological...any,announcedtodaythatitisscheduledtoparticipatein...nceatTheNewYorkPalaceHotelonDecember1,2009. ,, ...ofCryoLife,Inc.,willprovideacorporateoverviewregar...ndanswersessionat4:30p.m.EasternTime. ,, CryoLi...
(Date:11/23/2009)...Call/--WoundManagementTechnologies,Inc.,(OTCBullet...icalproducts,announcedthatithasfileditQ32009financ...sinessupdatetoillustratethedevelopmentsduringthe20...$102,926vs.Q32008salesof$77,084. , Shareholde...shareholderequityof$(321,257) , Totalassetsin...
(Date:11/23/2009)...all/--Pharmasset,Inc.(Nasdaq: VRUS )announcedtoday...X:ROG.VX;RO.S,OTCQX:RHHBY),willcontinuefortheremai...alofRG7128,afirst-in-classnucleosideanalogpolymera...(HCV)infection.Thedecisionwasreachedafteraschedule...ofallavailablesafetydatafromthefirstcohortofapprox...
Breaking Medicine Technology:CryoLife to Present at 21st Annual Piper Jaffray Health Care Conference 2Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 2Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 3Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 4Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 5Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 2Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 3Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 4Neogen Reports 18 25 Increase in Net Income 12 25 Increase in Revenues 14253 1Neogen Reports 18 25 Increase in Net Income 12 25 Increase in Revenues 14253 2Neogen Reports 18 25 Increase in Net Income 12 25 Increase in Revenues 14253 3Neogen Reports 18 25 Increase in Net Income 12 25 Increase in Revenues 14253 4Neogen Reports 18 25 Increase in Net Income 12 25 Increase in Revenues 14253 5Neogen Reports 18 25 Increase in Net Income 12 25 Increase in Revenues 14253 6Imagenetix Inc to Present at the 2009 RedChip New York Equities Conference 14251 1Imagenetix Inc to Present at the 2009 RedChip New York Equities Conference 14251 2Oncolytics Biotech 28R 29 Inc Announces Start of Enrolment in U S Phase 2 Melanoma Cancer Clinical Trial 5057 1Oncolytics Biotech 28R 29 Inc Announces Start of Enrolment in U S Phase 2 Melanoma Cancer Clinical Trial 5057 2Oncolytics Biotech 28R 29 Inc Announces Start of Enrolment in U S Phase 2 Melanoma Cancer Clinical Trial 5057 3Oncolytics Biotech 28R 29 Inc Announces Start of Enrolment in U S Phase 2 Melanoma Cancer Clinical Trial 5057 4
Other News:
...hildren has been far worse in the tallest, fastest... published in The International Journal of Obesity...University of Manchester say that faster-growing c...ening effects of the 'obesogenic environment,' tha...
...common in older people, and worsening gait is asso...However, factors contributing to gait difficulties...y by researchers at Rush University Medical Center...ctor associated with a decline in walking ability ...
U.S. Army soldiers who return from military deployment to the Iraq war have an increased risk for mild neuropsychological compromise, including poorer memory and sustained attention performance and gr
...search may finally settle a decades-old debate abo...om harmfully slipping into the urine, a serious he..... In genetically modified mice, scientists at Was... captured images of a defective version of a kidne...
health news:Big kids are getting too big 2health news:Higher blood pressure associated with decline in walking ability in older persons 2health news:Deployment to Iraq war associated with increased risk for adverse neuropsychological effects 2health news:Deployment to Iraq war associated with increased risk for adverse neuropsychological effects 3health news:Keep the baby, toss the bathwater: How kidneys retain proteins, discard waste 2health news:Keep the baby, toss the bathwater: How kidneys retain proteins, discard waste 3
... therapy given to babies after birth offers protec...rs from the Johns Hopkins Bloomberg School of Publ...rapine and zidovudine is 36 percent effective in b...ld. The researchers also report that giving these ...
...tudy from Malawi in this week's issue of THE LANCE... babies soon after childbirth (because their mothe...very) is still effective in preventing vertical HI.......Zidovudine and nevirapine have been shown to r...
...r researcher Dr. Owen Witte, who pioneered the res...kemia, has won the Leukemia & Lymphoma Society's p...ward.......The award, the highest scientific honor...e achievement in cancer research and recognizes hi...
...uggests that parents would rather send their child...cial anxiety disorder, a preference that has also ...deficit disorder therapy.......Parents "may be par..." say Denise Chavira, Ph.D., of the University of ...
health news:Antiretroviral therapy after birth decreases mother-to-child HIV transmission 2health news:Antiretrovirals reduce mother-to-child HIV-1 transmission when started after childbirth 2health news:Researcher at UCLA's Jonsson Cancer Center wins lifetime achievement award 2